Fig. 1
From: IL2RA is associated with persistence of rheumatoid arthritis
rs2104286 in IL2RA in relation to achieving DMARD-free sustained remission in RA patients of the Leiden EAC cohort. rs2104286 in IL2RA was significantly associated with achieving DMARD-free sustained remission in 645 RA patients (p = 2.44 × 10−3). The HR per minor C allele for achieving remission was 1.52 (95 % CI = 1.16–1.99). The analysis was adjusted for age, gender, and inclusion period (as a proxy for treatment strategy). DMARD disease-modifying antirheumatic drug, IL2RA interleukin-2 receptor alpha